Alterola Biotech, Inc. (ABTI)
Develops cannabis-based medicines for humans and animals
$0.00+0.00%Healthcare
StockGlow Score
Bearish
BearishBullish
1 year ago+0.0%
The outlook
ABTI is trading near its 52-week low with minimal analyst coverage available. The stock sits below both its 50- and 200-day moving averages, reflecting a weak near-term trend. Current market data shows a bearish lean overall.
What’s behind the score
Price trendBelow its 50- & 200-day averages
52-week range0% of the way from its 52-week low to high
Market cap
$291,900
52-wk high
$0.20
52-wk low
$0.00
50-day avg
$0.00
200-day avg
$0.00
Trailing P/E
—